Acyl-CoA Synthetase Medium-Chain Family Member 1 (ACSM1) (N-Term) Peptide

Details for Product No. ABIN698884
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

 
Protein Name
Synonyms BUCS1, MACS1, Macs, Acas3, Bucs1
Protein Region
N-Term
Application
Blocking Peptide (BP)
Pubmed 2 references available
Catalog no. ABIN698884
Quantity 0.1 mg
Price
49.50 $   Plus shipping costs $45.00
Options
Shipping to United States (Change)
Availability Will be delivered in 2 to 3 Business Days

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Specificity The synthetic peptide sequence used to generate the antibody AP9284a was selected from the N-term region of human ACSM1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Alternative Name ACSM1
Background ACSM1 has medium-chain fatty acid:CoA ligase activity with broad substrate specificity (in vitro). This protein acts on acids from C(4) to C(11) and on the corresponding 3-hydroxy-and 2,3-or 3,4-unsaturated acids (in vitro). This protein functions as GTP-dependent lipoate-activating enzyme that generates the substrate for lipoyltransferase
Comment

Background: ACSM1 has medium-chain fatty acid:CoA ligase activity with broad substrate specificity (in vitro). This protein acts on acids from C(4) to C(11) and on the corresponding 3-hydroxy-and 2,3-or 3,4-unsaturated acids (in vitro). This protein functions as GTP-dependent lipoate-activating enzyme that generates the substrate for lipoyltransferase

Restrictions For Research Use only
Storage 4 °C/-20 °C
Storage Comment Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Expiry Date 6 months
Background publications Sullivan, Lin, Tzeng et al.: "Genomewide association for schizophrenia in the CATIE study: results of stage 1." in: Molecular psychiatry, Vol. 13, Issue 6, pp. 570-84, 2008 (PubMed).

Celis, Gromov, Cabezón et al.: "15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma." in: Molecular & cellular proteomics : MCP, Vol. 7, Issue 10, pp. 1795-809, 2008 (PubMed).

back to top